Short communication · 10 Sep 2020
Research articlePublished 3 May 2019
Urolithiasis and its Management
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Urolithiasis is a disease known from ancient times, but still now the causes responsible for the formation of some of the different kind of stones are unknown, and consequently efficient therapeutic treatments have not yet been developed. Renal tract stones are common, more so in men, and among Asians and Caucasians, especially in warm climates. They are associated with a greater consumption of animal protein and refined foods, and decreased fluid intake. There are several types, most commonly consisting of calcium phosphates and oxalates; others are composed of magnesium ammonium phosphate (struvite), uric acid or cystine. Struvite stones are associated with urinary tract infections, often of urease-secreting bacteria that increase urinary ammonium concentration. Calcium stones may form for a number of reasons, including hypercalciuria and hyperoxaluria. Hypercalciuria may arise from changes to calcium resorption from bone, or renal and gastrointestinal tract handling of calcium; these are often associated with changes to parathyroid hormone secretion. Hyperoxaluria can arise from increased production or increased gut absorption. Other factors causing hypercalciuria include renal tubular acidosis or conditions that reduce the urinary concentrations of certain inhibitors, such as citrate and magnesium. Uric acid and cystine stones can form as a result of increased production or urinary concentration of the primary constituents. The assessment, investigation and management of patients with different types of stones are described
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 5 Aug 2013
An insight into molecular mechanism of urolithiasis: Identification of proteins from human renal stone matrix as drug targets
Research article · 8 Jun 2014
Chemical Composition of Urinary Stones in Patients with Urolithiasis in Sana’a, Yemen
Article · 2010
Chemical analysis of stones and its significance in urolithiasis
Case report · 26 Aug 2022
Ayurvedic management of paediatric urolithiasis (mutrashmari): A case report
More from this journal
The newest in Der Pharmacia Lettre.
Article · 28 Feb 2025
Review on: Oral Mucoadhesive Drug Delivery System
Article · 25 Jan 2025
Synthesis and Evaluation for Anti-Infective Activities of 2-Arylidene-1-(4-Methyl-6- Phenylpyrimidin-2-YL) Hydrazides
Article · 22 Jan 2025
Enzyme Inhibitors in Drug Resistance and Overcoming Therapeutic Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Narendra Vyas”
- BylineArticles whose byline prints “Raj K. Keservani”
- BylineArticles whose byline prints “Sarang Jain”
- BylineArticles whose byline prints “Ramsaneh Raghuvanshi”
- BylineArticles whose byline prints “Narayan P. Gavatia”
- BylineArticles whose byline prints “Amit K. Agrawal”
- BylineArticles whose byline prints “Rajesh K. Kesharwani”
